Heritage, a phase III safety and efficacy trial of the proposed trastuzumab biosimilar, Myl-1401O vs trastuzumab

Authors :: E.P. Yanez Ruiz
Joseph D. Parra
Sirshendu Ray
Cornelius F. Waller
Alexey Manikhas
Eduardo J. Pennella
Maria Luisa T. Abesamis-Tiambeng
I. Bondarenko
Jinyu Yuan
Gopichand Mamillapalli
M.H. Bronchud
Abhijit Barve
Gia Nemsadze
Hope S. Rugo
Jay Herson
Ihor Vynnychenko
Kakhaber Baramidze
Guzel Mukhametshina
Virote Sriuranpong
C. Akewanlop
Source :: Annals of Oncology. 27:vi555
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Trastuzumab
business.industry
medicine
Biosimilar
Hematology
Pharmacology
business
medicine.drug

Full Text Access

Tools